Physician profile
Aaron E White
NPI 1780670604
$13,190.69
in general payments reported to CMS, 2019-2025
44 companies · $2,092 in 2025
The $2,092 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $973 · 2020: $2,565 · 2021: $2,707 · 2022: $1,624 · 2023: $1,402 · 2024: $1,827 · 2025: $2,092.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,321.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,034.38 | 2020-2025 | Vraylar, Qulipta, Ubrelvy |
| Astrazeneca Pharmaceuticals Lp | $1,647.51 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Amarin Pharma, INC. | $965.16 | 2019-2022 | |
| Pfizer INC. | $921.77 | 2019-2025 | |
| Novo Nordisk INC | $910.63 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $867.78 | 2019-2025 | Repatha, Otezla, Otezla |
| Glaxosmithkline, LLC. | $858.56 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $644.67 | 2019-2024 | Jardiance |
| Lilly USA, LLC | $628.84 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $390.88 | 2021-2025 | Freestyle Libre, Freestyle Libre 3 |
| Allergan, INC. | $344.90 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $328.39 | 2019-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $276.53 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $260.61 | 2019-2025 | Xifaxan, Trulance |
| Biohaven Pharmaceuticals, INC. | $249.73 | 2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.